跳至主要内容
临床试验/NCT00301730
NCT00301730已完成1 期

Adoptive Immunotherapy With Costimulated Tumor-Derived T Cells After Allogeneic Hematopoietic Stem Cell Transplantation

National Cancer Institute (NCI)2 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2005年10月最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
1
试验地点
2

研究概览

简要总结

RATIONALE: Biological therapy, such as cellular adoptive immunotherapy, may stimulate the immune system in different ways and stop tumor cells from growing.

PURPOSE: This phase I trial is studying how well cellular adoptive immunotherapy works in treating a patient who has undergone a donor stem cell transplant for breast cancer that has spread to the lung.

详细描述

OBJECTIVES:

Primary

  • Determine the antitumor response in a patient with persistent metastatic breast cancer after prior allogeneic hematopoietic stem cell transplantation (SCT) treated with tumor-derived, ex vivo expanded and costimulated T-lymphocytes.

Secondary

  • Evaluate the immune function of tumor-derived T-lymphocytes and the biology of residual tumor cells present after allogeneic hematopoietic SCT.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

申办方类型
Nih

研究点 (2)

Loading locations...

相似试验

已完成
2 期
Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma MultiformeBrain and Central Nervous System Tumors
NCT00331526Hoag Memorial Hospital Presbyterian83
已完成
1 期
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic MeningiomaAnaplastic OligodendrogliomaEpendymoblastomaGiant Cell GlioblastomaGliosarcomaGrade III MeningiomaMeningeal HemangiopericytomaMixed GliomaGlioblastomaBrain Stem GliomaPineal Gland AstrocytomaBrain Tumor
NCT01082926City of Hope Medical Center6
已完成
1 期
Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV MelanomaRecurrent MelanomaStage IV Melanoma
NCT00438984Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium11
Unknown
1 期
A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid TumorsBreast CarcinomaHepatocellular CarcinomaNasopharyngeal Carcinoma
NCT01462903Sun Yat-sen University20
已完成
1 期
Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell TransplantMyelodysplastic SyndromesLeukemia
NCT00107354Fred Hutchinson Cancer Center